SCHEMBL29641985

SCHEMBL29641985

CCOC(=O)/C=C/c1cc(F)c(F)c(OCc2ccc(OC)cc2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MET P08581 5/20 0.50
▸ FDPS P14324 1/20 0.50
▸ TNFRSF1A P19438 1/20 0.50
▸ MAOB P27338 1/20 0.49
▸ CYP3A4 P08684 1/20 0.46
▸ ALOX5 P09917 2/20 0.44
▸ HDAC8 Q9BY41 2/20 0.44
▸ CASP3 P42574 1/20 0.44
▸ SENP7 Q9BQF6 1/20 0.44
▸ SENP6 Q9GZR1 1/20 0.44
▸ CA12 O43570 2/20 0.44
▸ CA7 P43166 2/20 0.44
▸ CA9 Q16790 2/20 0.44
▸ CA14 Q9ULX7 2/20 0.44
▸ CA1 P00915 1/20 0.44
▸ CA2 P00918 1/20 0.44
▸ FFAR1 O14842 1/20 0.44
▸ PPARG P37231 1/20 0.44
▸ PPARD Q03181 1/20 0.44
▸ PPARA Q07869 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29641993 0.88 FDPS (0.57) METFDPSTNFRSF1AMAOBCYP3A4
SCHEMBL22070946 0.87 TNFRSF1A (0.54) TNFRSF1AMAOBALOX5HDAC8CA9
SCHEMBL5685375 0.81 CA12 (0.55) METFDPSMAOBALOX5CA12
SCHEMBL5685380 0.81 CA12 (0.55) METFDPSMAOBALOX5CA12
SCHEMBL22070521 0.78 FFAR1 (0.46) MAOBFFAR1PPARGPPARDPPARA
SCHEMBL14253551 0.76 LMNA (0.61) FDPSMAOBCA12CA7CA9
SCHEMBL15668978 0.75 LMNA (0.53) FDPSCYP3A4ALOX5CA12CA7
SCHEMBL15668975 0.75 LMNA (0.53) FDPSCYP3A4ALOX5CA12CA7
4-Methoxy Ethyl Cinnamate SCHEMBL434842 0.75 CA12 (0.71) FDPSMAOBCYP3A4HDAC8CA12
4-Methoxy Ethyl Cinnamate SCHEMBL15190 0.75 CA12 (0.71) FDPSMAOBCYP3A4HDAC8CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11365192-B2 Pyridine compound substituted with azole TAISHO PHARMACEUTICAL CO., LTD. (JP) 2022-06-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11365192-B2 Pyridine compound substituted with azole CYP2C19, CYP4A11, CYP11B1 MET 1058/4885FDPS 106/4885TNFRSF1A 2858/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback